DRUG DELIVERY SYSTEM

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 该申请的长期目标是加强制药领域的基础设施。在制药药物输送研究活动的发展将促进本提案的目标，其中包括：a）开发关键的研究领域，这将促进在药学院的各种科学家之间的跨学科和学科内的研究环境。选定的关键领域之一是癌症，特别是肺癌; B）通过雇用关键人员来加强制药部门，以建立活跃的研究人员的临界质量; c）为少数民族科学家提供药物配制和输送领域的培训机会; d）为社区提供市场上各种新配方和药物输送装置的教育支持。上述目标的成功完成将使药学系能够在控制药物输送的广泛领域建立各种重点领域，并使该部门能够沿着吸引新的教师，促进与药物化学家和药理学家在药学FAMU学院的合作。此外，该中心的建立将使教师能够生成初步数据，以竞争R 01资金;开发用于治疗肺癌的新型吸入系统;并促进与即将成立的FSU医学院和生物医学工程系的合作。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The long-term objective of this application is to strengthen the infrastructure in the area of Pharmaceutics. The development of a drug delivery research activity in Pharmaceutics will facilitate the objectives of this proposal which include: a) develop key research areas which will foster an environment of inter and intradisciplinary research among various scientists at the College of Pharmacy. One of the key areas chosen is cancer with special emphasis on lung cancer; b) strengthen the Pharmaceutics division by the hiring of key personnel required to build a critical mass of active researchers; c) provide opportunities for the training of minority scientists in the area of drug formulation and delivery; and d) provide educational support for the community with the various new formulations and drug delivery devices on the market. The successful completion of the above listed objectives will enable the pharmaceutics faculty to build various focus areas in the broad area of controlled drug delivery and enable the division to attract new faculty along with facilitating collaboration with medicinal chemists and pharmacologists at the FAMU College of Pharmacy. Furthermore, the establishment of this center will allow the faculty to generate preliminary data to compete for R01 funding; develop novel inhalation systems for the treatment of lung cancer; and facilitate collaboration with the upcoming FSU medical school and biomedical engineering department.